@oakrest5
Active 11 hours ago
Significant correlations of CTRCD included treatment with trastuzumab (P = 0.001) or pertuzumab (P < 0.001), lower baseline global longitudinal strain (GLS) (P = 0.016), increased left ventricular end systolic diameter (P < 0.001), and lower e’ septal (P < 0.001).
CTRCD is an important concern among patients with active breast cancer, […] View
Sorry, there was no activity found. Please try a different filter.